Ceryvyn Therapeutics LimitedASX: CYV

Appendix 4G and Corporate Governance Statement

· Issued by Ceryvyn Therapeutics Limited via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Ceryvyn Therapeutics Limited ABN/ARBN Financial year ended: 32 006 340 567 30 June...

View Attachment

6ix hasn’t read this filing yet.

Ceryvyn Therapeutics Limited on 6ix

Earlier from Ceryvyn Therapeutics

Later from Ceryvyn Therapeutics

All Ceryvyn Therapeutics news releases